REBECCA BATTLESON: Open Payments
NPI 1134732787 · IRVING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$625 in 33 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $625
Food & beverage: $625
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $156 |
| Exact Sciences Corporation | 4 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $92 |
| Lilly USA, LLC | 4 | $66 |
| Novo Nordisk Inc | 3 | $50 |
| GlaxoSmithKline, LLC. | 2 | $49 |
| ABBVIE INC. | 2 | $36 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
Products named: JARDIANCE, The Cologuard Plus Collection Kit, MOUNJARO, BREZTRI, AIRSUPRA, FARXIGA, VRAYLAR, Ozempic.
Industry payments across TX — which companies pay providers there.
